TACSTD2 and cancer: Importantly, because Trop-2 overexpression may represent an independent prognostic factor for earlier cancer recurrence, its determination in EEC tissue samples may be clinically useful in the attempt to identify patients at higher risk of relapse before surgery and, subsequently, to optimize follow up and adjuvant treatments.